Back to article: VDAC1 at the crossroads of cell metabolism, apoptosis and cell stress


FIGURE 5: VDAC1 function in cell death, with apoptosis inducers enhancing VDAC1 expression levels and oligomerization. A schematic representation of VDAC1 function in cell death – Different models for the release of apoptogenic proteins, such as Cyto c (purple) and AIF (yellow), are shown. (A) Proposed model suggesting that apoptotic stimuli or conditions cause enhanced VDAC1 expression via increases in [Ca2+]i levels or transcription factors, leading to activation of the VDAC1 promoter. The increase in VDAC1 expression shifts the equilibrium towards the VDAC1 oligomeric state, forming a hydrophilic protein-conducting channel capable of mediating the release of apoptogenic proteins (e.g., Cyto c and AIF) from the mitochondrial IMS to the cytosol. (B) Mitochondrial Ca2+ overload induces apoptosis. Ca2+ transport across the OMM, as mediated by VDAC1, and then across the IMM, as mediated by the MCU, leads to Ca2+ overload in the matrix. This, in turn, causes dissipation of the membrane potential, mitochondrial swelling, PTP opening, Cyto c/AIF release and the triggering of apoptotic cell death. (C) Bax/Bak oligomerization and activation, forming a route for Cyto c/AIF release. (D) Bax activation leads to its association with the OMM, followed by its oligomerization as a large oligomer/complex, forming a Cyto c/AIF-conducting channel. (E) The interaction of the pro-apoptotic protein Bax with VDAC1 forms hetro-oligomers that mediate Cyto c/AIF release. (F) Prolonged VDAC1 closure leads to mitochondrial matrix swelling and OMM rupture, resulting in the appearance of a non-specific release pathway for apoptogenic proteins.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. Please refer to our "privacy statement" and our "terms of use" for further information.

Close